Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-07-18FDA Approved: PREGABALIN — Original Application (MARKSANS PHARMA LIMITED)
FDA approved the original ANDA for pregabalin from Marksans Pharma Limited (ANDA216197).
-
FDA approval · 2022-03-22FDA Approved: PREGABALIN — Original Application (Advagen Pharma Ltd.)
FDA approved Pregabalin under an Original Application for Advagen Pharma Ltd., authorizing the generic product.
-
FDA approval · 2022-03-08FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).
-
FDA approval · 2022-02-18FDA Approved: PREGABALIN — Original Application (Patrin Pharma, Inc.)
FDA approved an original application for pregabalin from Patrin Pharma, making a generic version available. This marks the approval of a gen…
-
FDA approval · 2022-01-25FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
-
FDA approval · 2021-09-20FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) from Allergan, updating the product labeling.
-
FDA approval · 2021-07-23FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Drizalma Sprinkle, a duloxetine product, expanding the label to include a sprinkle-form dosa…
-
FDA approval · 2021-07-15FDA Approved: PREGABALIN — Original Application (Tris Pharma Inc)
The FDA approved Tris Pharma's original Abbreviated New Drug Application for pregabalin, allowing a generic pregabalin product to enter the …
-
FDA approval · 2021-05-19FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Amitriptyline hydrochloride as an original-application generic from Unichem Pharmaceuticals (USA), Inc. (ANDA 214548).
-
FDA approval · 2021-04-13FDA Approved: PREGABALIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original abbreviated new drug application for pregabalin from Novadoz Pharmaceuticals LLC, enabling a generic version of pr…
-
FDA approval · 2020-12-30FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for duloxetine (ANDA204343), enabling the continued marketing of the gener…
-
FDA approval · 2020-10-01FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2020-04-20FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly, granting updated labeling under the NDA.
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…
-
FDA approval · 2020-03-23FDA Approved: PREGABALIN — Original Application (Creekwood Pharmaceuticals LLC)
FDA approves Creekwood Pharmaceuticals LLC's Original Application (ANDA) for pregabalin, enabling a generic version of the drug. This action…
-
FDA approval · 2020-03-20FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.
-
FDA approval · 2019-12-13FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental abbreviated new drug application for duloxetine hydrochloride from Aurobindo Pharma Limited (ANDA 090778), e…
-
FDA approval · 2019-11-29FDA Approved: PREGABALIN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for pregabalin from Sun Pharmaceutical Industries, authorizing a generic version of pregabalin.
-
FDA approval · 2019-10-08FDA Approved: PREGABALIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original Abbreviated New Drug Application for pregabalin, a generic version of the brand product.
-
FDA approval · 2019-08-16FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved the original application for duloxetine hydrochloride from Yaopharma Co., Ltd., granting approval for the generic product to be…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Cipla USA, Inc.)
FDA approves Cipla USA, Inc.'s original application for pregabalin, granting a generic version of the drug for its established indications.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen Pharmaceuticals' original application for pregabalin (generic pregabalin), enabling the generic product to be marketed …
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (AvPAK)
FDA approved AvPAK's original application for pregabalin, enabling the generic version to enter the market.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for pregabalin (generic) submitted by Rising Pharma Holdings, Inc., authorizing its market authorizati…